Loading...
HSChapter 30
U.S. imports of antimalarial medicaments in measured doses for retail sale (HS 300460) totaled $539K in July 2026, traded with 7 countries.
Antimalarial Medicaments in Measured Doses for Retail Sale imports of $539K in July 2026 ran 57% above the year-to-date monthly average of $344K.
Last updated: July 2026 dataFinished-dose antimalarial preparations whose active ingredients are defined by Subheading Note 2 to Chapter 30 are classified under tariff line 3004600000. This heading was introduced in the HS 2017 revision to separately track artemisinin-based combination therapies (ACTs) and other priority antimalarials, reflecting global public health policy goals around access to these medicines. FDA regulates imported antimalarial drug products through its standard drug approval and foreign establishment registration framework, and importers should verify that the specific active ingredient qualifies under the applicable subheading note rather than defaulting to the residual 300490 heading. Supply chains for antimalarials often involve manufacturers in Asia, and importers should confirm that foreign establishments are on FDA's approved list prior to shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
5 shipments/mo
Classification in 300460 requires that the active antimalarial substance be one of those specifically enumerated in Subheading Note 2 to Chapter 30. Artemisinin derivatives and certain combination therapies are the primary targets of this note. If the active ingredient is not listed in that note, the product falls to the residual heading 300490. Importers should review the current Subheading Note text and consult a licensed customs broker to confirm eligibility.
Antimalarial medicaments are not broadly subject to Section 301 or antidumping measures as a category, but duty treatment can vary by country of origin. Importers should verify the current tariff schedule and any applicable trade-remedy orders for the specific country of manufacture, as pharmaceutical supply chains frequently involve multiple countries for API sourcing and finished-dose manufacturing. Consult a licensed customs broker for origin determination and admissibility review.
Supplier Network
Get discovered by U.S. importers searching for HS 300460 — Antimalarial Medicaments in Measured Doses for Retail Sale. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share |
|---|---|---|---|---|
| 3004600000 | Other Meds,Antimalarial in Subh Note 2,Measured | $539K | 0.00% | 0.00% |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004600000 | Other Meds,Antimalarial in Subh Note 2,Measured | $30K |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$539KYoY · Pro
Exports
$30KYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Imports · July 2026
origin
Italy and Switzerland together supply 61% of it.
customs district
destination
entry
rate provision · imports
100.0% enters free of duty; the effective duty rate is 0.00%.